Filing Details

Accession Number:
0001209191-20-029918
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-15 21:02:42
Reporting Period:
2020-05-15
Accepted Time:
2020-05-15 21:02:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
873303 Sarepta Therapeutics Inc. SRPT Pharmaceutical Preparations (2834) 930797222
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1562371 Richard Barry 215 First Street, Suite 415
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-15 25,327 $141.12 3,163,813 No 4 S Direct
Common Stock Disposition 2020-05-15 4,673 $142.05 3,159,140 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares were sold in transactions at prices ranging from $140.60 to $141.54, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  2. The shares were sold in transactions at prices ranging from $142.00 to $142.30, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.